Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Elevated Polyamines in Saliva of Pancreatic Cancer

Version 1 : Received: 10 January 2018 / Approved: 10 January 2018 / Online: 10 January 2018 (15:32:48 CET)

A peer-reviewed article of this Preprint also exists.

Asai, Y.; Itoi, T.; Sugimoto, M.; Sofuni, A.; Tsuchiya, T.; Tanaka, R.; Tonozuka, R.; Honjo, M.; Mukai, S.; Fujita, M.; Yamamoto, K.; Matsunami, Y.; Kurosawa, T.; Nagakawa, Y.; Kaneko, M.; Ota, S.; Kawachi, S.; Shimazu, M.; Soga, T.; Tomita, M.; Sunamura, M. Elevated Polyamines in Saliva of Pancreatic Cancer. Cancers 2018, 10, 43. Asai, Y.; Itoi, T.; Sugimoto, M.; Sofuni, A.; Tsuchiya, T.; Tanaka, R.; Tonozuka, R.; Honjo, M.; Mukai, S.; Fujita, M.; Yamamoto, K.; Matsunami, Y.; Kurosawa, T.; Nagakawa, Y.; Kaneko, M.; Ota, S.; Kawachi, S.; Shimazu, M.; Soga, T.; Tomita, M.; Sunamura, M. Elevated Polyamines in Saliva of Pancreatic Cancer. Cancers 2018, 10, 43.

Abstract

Detection of pancreatic cancer (PC) at a resectable stage is still difficult because of the lack of accurate detection tests. The development of accurate biomarkers in low or non-invasive biofluids is essential to enable frequent tests, which would help increase the opportunity of PC detection in early stages. Polyamines have been reported as possible biomarkers in urine and saliva samples in various cancers. Here, we analyzed salivary metabolites, including polyamines, using capillary electrophoresis-mass spectrometry. Salivary samples were collected from patients with PC (n=39), chronic pancreatitis (CP, n=14) and controls (C, n=26). Polyamines, such as spermine, N1-acetylspermidine, and N1-acetylspermine, showed a significant difference between PC and C, and the combination of four metabolites including N1-acetylspermidine showed high accuracy in discriminating PC from the other two groups. These data showed the potential of saliva as a screening test for PC.

Keywords

pancreatic cancer; saliva; metabolomics; polyamines

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.